Dudediligence.

Outlook Therapeutics, Inc

OTLKNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Reported ·

$5,305,700

0 sales · 6 buys

Oct 2025 to Jun 2026

REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-05-26: HILZINGER KURT J, bought2026-05-26: THURMAN RANDY H, bought2026-05-26: Haddadin Yezan Munther, bought2026-05-27: Sukhtian Faisal Ghiath, bought2026-05-28: Sukhtian Ghiath M., bought2026-06-02: Haddadin Yezan Munther, bought
under a no plan named▲ buysize is dollars

Form 4 filings, newest first

2026-06-02Haddadin Yezan Munther$24,070
▲ bought29,000 shno plan namedForm 4 ↗
2026-05-28Sukhtian Ghiath M.$5,038,428
▲ bought8,539,709 shno plan namedForm 4 ↗
2026-05-27Sukhtian Faisal Ghiath$50,091
▲ bought122,174 shno plan namedForm 4 ↗
2026-05-26HILZINGER KURT J$176,000
▲ bought400,000 shno plan namedForm 4 ↗
2026-05-26THURMAN RANDY H$2,150
▲ bought5,000 shno plan namedForm 4 ↗
2026-05-26Haddadin Yezan Munther$14,960
▲ bought34,000 shno plan namedForm 4 ↗